glp 1 and loss of muscle mass GLP-1 Loss: Semaglutide, Tirzepatide & Lean Nutritional deficiencies and muscle loss

demonstrated that GLP-1 RAs could alleviate cytoplasmic Ca 2+ overload in VSMCs in SHRs, improve the arterioles systolic and diastolic functions, and reduce BPV by upregulating Na + /Ca 2+ exchanger 1 (NCX1) expression via the Akt signaling pathway [80]

Pancreatology 2003

Unlike currently available GLP-1 drugs (glucagon-like peptide 1) including semaglutide, sold as Ozempic and Wegovy, aleniglipron is a small-molecule drug that is taken orally and is currently in development for the treatment of obesity

Recent pharmacovigilance data and population studies continue to refine our understanding of this potential complication